Sabra保健REIT达到了Q4收入,提高了红利,但略微降低了2025财政年度的指导意见。 Sabra Health Care REIT met Q4 earnings, raised dividend, but slightly lowered FY 2025 guidance.

Sabra保健REIT达到Q4收入预期值0.36美元,2025财政年度指南更新为1.430-1.460 EPS,略低于1.480的共识。 Sabra Health Care REIT met Q4 earnings expectations at $0.36 EPS and updated FY 2025 guidance to 1.430-1.460 EPS, slightly below the consensus of 1.480. 股票增加了0.09美元,增至16.55美元。 Shares rose by $0.09 to $16.55. 该公司宣布了0.30美元的季度红利,将年化红利提高到1.20美元,收益率为7.25%。 The company announced a $0.30 quarterly dividend, boosting the annualized dividend to $1.20 and a yield of 7.25%. 尽管分析家意见不一, Sabra仍获得“机动买”共识评级,目标价为18.86美元。 Despite varied analyst opinions, Sabra has a "Moderate Buy" consensus rating with a target price of $18.86.